Teyi Pharmaceutical Group Co.,Ltd (SZSE: 002728)
Health Care · Pharmaceuticals · CN
CN¥8.90
-5.32% today · -5.7% 1Y
Teyi Pharmaceutical Group Co.,Ltd (SZSE: 002728) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $661.41M and employs 1,621 people.
Over the last twelve months the share price has lost 5.7%, trading between 7.66 and 15.21.
Tweenvest scores Teyi Pharmaceutical Group Co.,Ltd across four factors: quality 71/100, value 22/100, growth 86/100, dividend 55/100. Its strongest factor is growth.
002728 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $661.41M
- Revenue (TTM)
- $121.70M
- P/E
- 63.34
- EPS
- 0.14
- Dividend yield
- 1.69%
- Beta (5Y)
- 1.35
- 52-week high
- CN¥15.21
- 52-week low
- CN¥7.66
- Avg volume (3M)
- —
- Shares outstanding
- 499.58M
- Employees
- 1,621
- Next earnings
- —
About Teyi Pharmaceutical Group Co.,Ltd
Teyi Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company that focuses on the development, production, and sale of a broad range of medicinal products within China. Its offerings include both proprietary traditional Chinese medicines (TCMs) and various chemical products, such as finished preparations, raw materials, and other related chemical compounds. The company's portfolio of finished drugs targets several key therapeutic areas, including respiratory conditions (like cough and phlegm), kidney-related ailments, infectious diseases, cardiovascular issues, and digestive system disorders. Beyond finished medications, Teyi Pharmaceutical also supplies a variety of chemical raw materials and products; notable examples include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth and citric acid series compounds, and zinc sulfate. Based in Taishan, China, the company underwent a name change in November 2016, transitioning from its previous identity as Guangdong Taicheng Pharmaceutical Co., Ltd. to its current name, Teyi Pharmaceutical Group Co., Ltd.
- ISIN
- CNE100001WK6
- Founded
- 2002
- Listed since
- Jul 31, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,247.37 | -0.64% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.00 | +1.02% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.91 | -1.08% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.14% |
Figures last refreshed Aug 18, 2026.